Published in Lancet on July 15, 1967
Cutaneous vasculitis: antigen-antibody complexes and prolonged fibrinolysis. Proc R Soc Med (1972) 1.46
Fibrinolytic and fibrin stabilizing activity of synovial membranes. Ann Rheum Dis (1970) 1.36
Immunohistochemical localisation of tissue plasminogen activator and urokinase in the vessel wall. J Clin Pathol (1985) 1.13
[Quantitative determination of the fibrinolytic tissue activator in normal and pathological skin]. Arch Klin Exp Dermatol (1968) 0.97
Spontaneous fibrinolysis in pulmonary embolism. J Clin Invest (1971) 0.93
Venous ulceration, fibrinogen and fibrinolysis. Ann R Coll Surg Engl (1984) 0.85
Plasminogen activator in the human prostate. J Clin Pathol (1969) 0.82
Localization of tissue plasminogen activator in relation to morphologic changes in human saphenous veins used as coronary artery bypass autografts. Ann Surg (1975) 0.81
Method for measuring fibrinolytic activity in a single layer of cells. J Clin Pathol (1981) 0.80
Plasminogen activators: a morphologist's view. J Clin Pathol Suppl (R Coll Pathol) (1980) 0.75
Fibrinolytic activity in malignant disease. J Clin Pathol (1975) 0.75
A simple quantitative assay of tissue plasminogen activator. J Clin Pathol (1982) 0.75
Clinical experience with brinase. J Clin Pathol (1972) 0.75
A simple quantitative assay of vascular plasminogen activator--not only stimulated fibrinolytic activity but also basal fibrinolytic activity are correlated with venous fibrinolytic activity. Korean J Intern Med (1990) 0.75
Myocardium as contributor of plasminogen activator to blood. Br Heart J (1971) 0.75
The scanning electron microscopy of the lysis of fibrin by endothelium. Br J Exp Pathol (1975) 0.75
Blood clotting and contraception. Br Med J (1971) 0.75
Fibrinolytic capacity of arm and leg veins after femoral shaft fracture and acute myocardial infarction. Br Med J (1975) 0.75
A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology (1997) 7.72
The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatry (1991) 4.43
A randomized trial of group outpatient visits for chronically ill older HMO members: the Cooperative Health Care Clinic. J Am Geriatr Soc (1997) 4.09
Driven DNA transport into an asymmetric nanometer-scale pore. Phys Rev Lett (2000) 4.06
Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol (1998) 3.77
Molecular pathology of haemophilia B. EMBO J (1989) 2.74
Rapid reverse transcription-PCR detection of hepatitis C virus RNA in serum by using the TaqMan fluorogenic detection system. J Clin Microbiol (1996) 2.72
Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med (1988) 2.53
Simultaneous multianalyte detection with a nanometer-scale pore. Anal Chem (2001) 2.17
Effect of oral administration of various beta-blocking agents on the intraocular pressure in healthy volunteers. Exp Eye Res (1975) 2.14
Long-term results of endoscopic management of postoperative bile duct strictures with increasing numbers of stents. Gastrointest Endosc (2001) 2.13
The natural course of gallstone disease: eleven-year review of 781 nonoperated cases. Gastroenterology (1966) 2.11
Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy. N Engl J Med (1994) 2.09
Blindness after reduction of facial fractures. Plast Reconstr Surg (1998) 2.08
Pulmonary epithelial permeability. An animal study of inverse ratio ventilation and conventional mechanical ventilation. Chest (1996) 2.02
A functional role for the two-pore domain potassium channel TASK-1 in cerebellar granule neurons. Proc Natl Acad Sci U S A (2000) 2.01
Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics (1999) 2.01
Thromboembolic disease--critical evaluation of laboratory investigation. Thromb Haemost (1992) 1.93
In vivo lung lavage as an experimental model of the respiratory distress syndrome. Acta Anaesthesiol Scand (1980) 1.86
The impact of nausea and vomiting upon quality of life measures. Br J Cancer Suppl (1992) 1.81
Interacting proteins identified by genetic interactions: a missense mutation in alpha-tubulin fails to complement alleles of the testis-specific beta-tubulin gene of Drosophila melanogaster. Mol Cell Biol (1989) 1.80
Inhibitory post-synaptic currents in rat hippocampal CA1 neurones. J Physiol (1984) 1.79
AHF related protein in clinical praxis. Scand J Haematol (1974) 1.78
Surfactant treatment and incidence of intraventricular haemorrhage in severe respiratory distress syndrome. Arch Dis Child (1988) 1.76
Defective fibrinolysis in blood and vein walls in recurrent "idiopathic" venous thrombosis. Acta Chir Scand (1972) 1.74
Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics (1992) 1.71
Blood Transfusion in Severe Burns in Infants and Young Children: A Preliminary Report of the Treatment of the Toxic Shock by Blood Transfusion-with or without preceding exsanguination. Can Med Assoc J (1921) 1.71
The pulmonary surfactant system: biochemical aspects and functional significance. Physiol Rev (1988) 1.69
Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant. Characterization and biophysical activity. Eur J Biochem (1987) 1.67
The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots. Nucleic Acids Res (1990) 1.64
Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol Suppl (R Coll Pathol) (1980) 1.64
Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med (1999) 1.61
Measurement of quality of life in patients with cancer. Cancer Surv (1987) 1.60
Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest (1994) 1.60
A radiologic classification of hemophilic arthropathy. Clin Orthop Relat Res (1980) 1.59
Hepatitis C virus transmission by monoclonal antibody purified factor VIII concentrate. Lancet (1990) 1.53
Intrauterine death and circulating anticoagulant ("antithromboplastin"). Acta Med Scand (1975) 1.51
A nascent secretory protein may traverse the ribosome/endoplasmic reticulum translocase complex as an extended chain. J Biol Chem (1996) 1.51
Patch-clamp recordings from cerebellar basket cell bodies and their presynaptic terminals reveal an asymmetric distribution of voltage-gated potassium channels. J Neurosci (1998) 1.50
Determination of plasminogen in clots and thrombi. Thromb Diath Haemorrh (1966) 1.48
Coagulation and fibrinolytic studies during pregnancy. Acta Obstet Gynecol Scand (1967) 1.48
Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol (1975) 1.47
Haemophilia prophylaxis in Sweden. Acta Paediatr Scand (1976) 1.46
Hydrophobic surfactant-associated polypeptides: SP-C is a lipopeptide with two palmitoylated cysteine residues, whereas SP-B lacks covalently linked fatty acyl groups. Proc Natl Acad Sci U S A (1990) 1.45
Hyperpolarization-activated currents in presynaptic terminals of mouse cerebellar basket cells. J Physiol (2000) 1.45
Haemophilia prophylaxis in young patients--a long-term follow-up. J Intern Med (1997) 1.44
Intravascular coagulation and acute renal failure in a child with mycoplasma infection. Acta Med Scand (1971) 1.44
Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res (1997) 1.42
Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med (1994) 1.42
Molecular characterization of the her-1 gene suggests a direct role in cell signaling during Caenorhabditis elegans sex determination. Genes Dev (1993) 1.41
The proteins of the surfactant system. Eur Respir J (1994) 1.40
[Threatened future of plasma products. Who is responsible?]. Lakartidningen (1996) 1.39
Electrophysiological characterization of voltage-gated K(+) currents in cerebellar basket and purkinje cells: Kv1 and Kv3 channel subfamilies are present in basket cell nerve terminals. J Neurosci (2000) 1.39
Pulmonary surfactant from healthy Belgian White and Blue and Holstein Friesian calves: biochemical and biophysical comparison. Vet J (2003) 1.39
Abnormalities of the costochondral junction in cases of perinatal death, with special reference to hyaline membrane disease. Acta Pathol Microbiol Scand (1969) 1.38
Subunit principles in midface fractures: the importance of sagittal buttresses, soft-tissue reductions, and sequencing treatment of segmental fractures. Plast Reconstr Surg (1999) 1.37
The effect of an introductory letter on participation rates using telephone recruitment. Aust N Z J Public Health (2000) 1.33
Long-term physical impairment and functional outcomes after complex facial fractures. Plast Reconstr Surg (2001) 1.33
The dual role of interferon-gamma in experimental Staphylococcus aureus septicaemia versus arthritis. Immunology (1998) 1.30
Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid. Scand J Haematol (1965) 1.29
Prolongation of inhibitory postsynaptic currents by pentobarbitone, halothane and ketamine in CA1 pyramidal cells in rat hippocampus. Br J Pharmacol (1985) 1.29
Expression of periostin in human breast cancer. J Clin Pathol (2007) 1.28
Regulation of intraocular pressure and pupil size by beta-blockers and epinephrine. Arch Ophthalmol (1980) 1.27
Lung expansion in the premature rabbit fetus after tracheal deposition of surfactant. Pediatrics (1972) 1.26
Two genetic variants of von Willebrand's disease. N Engl J Med (1973) 1.25
Dendrotoxins: structure-activity relationships and effects on potassium ion channels. Curr Med Chem (2004) 1.25
IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. J Immunol (1992) 1.24
Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC). J Clin Invest (1982) 1.23
[Risk of thromboembolism with oral contraceptives]. Lakartidningen (1967) 1.23
Interacting genes identify interacting proteins involved in microtubule function in Drosophila. Cell Motil Cytoskeleton (1989) 1.19
Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Br Med J (Clin Res Ed) (1985) 1.19
Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model. Neuropathol Appl Neurobiol (2001) 1.18
Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease. N Engl J Med (1983) 1.18
Aetiological agent of enterically transmitted non-A, non-B hepatitis. J Gen Virol (1988) 1.18
Capsaicin causes prolonged inhibition of voltage-activated calcium currents in adult rat dorsal root ganglion neurons in culture. Neuroscience (1991) 1.18
Multiple stenting of refractory pancreatic duct strictures in severe chronic pancreatitis: long-term results. Endoscopy (2006) 1.18
Low-molecular-mass surfactant protein type 1. The primary structure of a hydrophobic 8-kDa polypeptide with eight half-cystine residues. Eur J Biochem (1988) 1.17
Surfactant dysfunction makes lungs vulnerable to repetitive collapse and reexpansion. Am J Respir Crit Care Med (1997) 1.16
Comprehensive management of pan-facial fractures. J Craniomaxillofac Trauma (1995) 1.16
Treatment of ocular hypertension with oral beta-adrenergic blocking agents. Acta Ophthalmol (Copenh) (1974) 1.15
Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer. Ann Oncol (2008) 1.14
Coagulation and fibrinolytic studies during use of gestagens. Acta Obstet Gynecol Scand (1967) 1.14
Lung surfactant and the pathogenesis of neonatal bronchiolar lesions induced by artificial ventilation. Pediatr Res (1978) 1.13
Catheter material and blood coagulation studies in vitro. Scand J Haematol (1969) 1.13
Fibrinolysis in newborns. Acta Paediatr Scand (1970) 1.12
Surface activity of lipid extract surfactant in relation to film area compression and collapse. J Appl Physiol (1985) (1994) 1.12
Involvement of prostaglandins in the immune alterations caused by the exposure of mice to ultraviolet radiation. J Immunol (1986) 1.12
New aspects of the pathogenesis of thrombo-embolism. Prog Surg (1973) 1.11
On the mechanism of 4-aminopyridine action on the cloned mouse brain potassium channel mKv1.1. J Physiol (1994) 1.10
Transganglionic transport and binding of the isolectin B4 from Griffonia simplicifolia I in rat primary sensory neurons. Neuroscience (1994) 1.10
Improved ventilation of prematurely delivered primates following tracheal deposition of surfactant. Am J Obstet Gynecol (1978) 1.09
Fibrin degradation products and ovarian tumours. Br Med J (1971) 1.08
Thrombolytic effect of streptokinase as evaluated by phlebography of deep venous thrombi of the leg. Acta Chir Scand (1970) 1.08
The role of the low-molecular weight (less than or equal to 15,000 daltons) apoproteins of pulmonary surfactant. Eur J Respir Dis (1986) 1.08